Corton Capital Inc. Kura Oncology, Inc. Transaction History

Corton Capital Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$8.44 - $11.86 $8,591 - $12,073	1,018 Added 5.85%	18,409 $167,000
Q2 2023 Aug 14, 2023	BUY	$9.62 - $13.99 $167,301 - $243,300	17,391 New	17,391 $183,000
Q2 2022 Aug 15, 2022	SELL	$10.71 - $18.33 $18,046 - $30,886	-1,685 Reduced 13.94%	10,400 $191,000
Q1 2022 May 16, 2022	BUY	$11.78 - $16.98 $142,361 - $205,203	12,085 New	12,085 $194,000

185

81.8M

42.1K

34K

Ticker KURA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 66,893,000
Market Cap $598M
Description
Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...

Get notified when there are updates to the investment portfolio of Corton Capital Inc., based on Form 13F filings with the SEC.

Stay updated on Corton Capital Inc. with notifications on news.